ULTOMIRIS conc perf 300 mg/30ml flac 30 ml
7680672780016
CH-67278
L04AJ02
07.15.0.
Active substances:
1 / 2
google
Details
- Product number
- 6727801
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- ravulizumabum 300 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 30 ml corresp. natrium 115 mg.
Articles (1)
Ultomiris 300 mg/30 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
ravulizumabum
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
natrii dihydrogenophosphas monohydricus
|
- | Substance | HNIDK |
|
dinatrii phosphas heptahydricus
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
115.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 4181.20
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2020
Authorization holder
Alexion Pharma GmbH
6340 Baar
Authorization information
- Swissmedic authorization number
- 67278
- Drug name
- Ultomiris, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L04AJ02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 20/01/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ULTOMIRIS conc perf 300 mg/30ml flac 30 ml
- Description (DE)
- ULTOMIRIS Inf Konz 300 mg/30ml Durchstf 30 ml
- Market launch
- 20/01/2020
- Narcotic (BTM)
- No